Deerfield
About Deerfield

Launched in 1994, Deerfield Management Company is an investment firm dedicated to advancing healthcare through information, investment, and philanthropy—all toward the end goal of cures for disease, improved quality of life, and reduced cost of care.

Read More
---
Investment

Supporting companies across the healthcare ecosystem with flexible funding models…

Read More
---
Information

Delivering market research to the Deerfield team, its portfolio companies and other partners.

Read More ---
Philanthropy

A New York City-based not-for-profit devoted to advancing innovative health care initiatives.

Read More
---
Research Collaborations

Deerfield partners with leading academic research centers, providing critical funding and expertise to further sustain and accelerate the commercialization of discoveries toward meaningful societal impact by advancing cures for disease.

Read More
---
Strategic Partners

As a strategic partner, Deerfield offers capital, scientific expertise, business operating support, and unique access to innovation.

---
Deerfield Foundation

The Deerfield Foundation is a New York City-based not-for-profit organization whose mission is to improve health, accelerate innovation and promote human equity.

Read More Meet the Foundation Team
---
Cure Campus

Cure is a 12-story innovations campus in New York City that intends to bring together innovators from academia, government, industry, and the not-for-profit sectors to advance human health and accelerate the fight against disease.

Read More Meet the Cure Team Join the Cure Email List
Cure Programming

Cure has a series of expert lectures intended to advance thought in healthcare, management, innovation, policy, and other relevant subjects. This fosters growth and education for those at Cure and its guests.

Cure Symposium Calendar

Jessie Hou

Jessie Hou is a Director, Forecasting, in the Deerfield Institute and joined Deerfield in 2021. Prior to Deerfield, Ms. Hou spent six years at Boehringer Ingelheim, most recently as Senior Associate Director, Specialty Care Forecasting. Previously to that, Ms. Hou was Associate Manager of a corporate venture capital fund at Ajinomoto Group, Consultant at 21Ventures and Scientist at Shire Pharmaceuticals (now part of Takeda Pharmaceutical Company). Ms. Hou holds B.S. in Chemical Engineering from Tsinghua University in Beijing, an M.S. from the University of Wisconsin-Madison in Chemical & Biological Engineering, and an M.B.A. from the NYU-Stern School of Business. She is also a CFA charterholder.